BDRX CIK: 1643918

Biodexa Pharmaceuticals Plc

  • United Kingdom
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions GBP
FY21:
11.8
FY22:
4.69
FY23:
7.03
FY24:
8.81
FY25:
12.4
(positive)
Change from FY21 to FY25
millions GBP
FY21:
1.15
FY22:
0.84
FY23:
3.51
FY24:
5.97
FY25:
5.74
Total assets
Change from FY21 to FY25
millions GBP
FY21:
12.9
FY22:
5.53
FY23:
10.5
FY24:
14.8
FY25:
18.2

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions GBP
FY21:
1.84
FY22:
1.90
FY23:
5.57
FY24:
5.03
FY25:
6.13
(negative)
Change from FY21 to FY25
millions GBP
FY21:
0.62
FY22:
0.46
FY23:
0.30
FY24:
1.42
FY25:
0.65
(positive)
Change from FY21 to FY25
millions GBP
FY21:
10.5
FY22:
3.16
FY23:
4.68
FY24:
8.32
FY25:
11.4
Total liabilities & equity
Change from FY21 to FY25
millions GBP
FY21:
12.9
FY22:
5.53
FY23:
10.5
FY24:
14.8
FY25:
18.2

All amounts in millions GBP Data sources:SEC EDGARTwelve Data